Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ask120067
2. 1934259-00-3
3. N-[5-[[5-chloro-4-(naphthalen-2-ylamino)pyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide
4. Prj2ua27t7
5. Schembl17792773
6. Glxc-27333
7. Akos040754907
8. Ask-120067
9. Ms-30015
10. Hy-138751
11. Cs-0168076
12. G18197
13. 2-propenamide, N-(5-((5-chloro-4-(2-naphthalenylamino)-2-pyrimidinyl)amino)-2-((2-(dimethylamino)ethyl)methylamino)-4-methoxyphenyl)-
| Molecular Weight | 546.1 g/mol |
|---|---|
| Molecular Formula | C29H32ClN7O2 |
| XLogP3 | 5.7 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 11 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 94.6 |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 789 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
48
PharmaCompass offers a list of Limertinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Limertinib manufacturer or Limertinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Limertinib manufacturer or Limertinib supplier.
PharmaCompass also assists you with knowing the Limertinib API Price utilized in the formulation of products. Limertinib API Price is not always fixed or binding as the Limertinib Price is obtained through a variety of data sources. The Limertinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Limertinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Limertinib, including repackagers and relabelers. The FDA regulates Limertinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Limertinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Limertinib supplier is an individual or a company that provides Limertinib active pharmaceutical ingredient (API) or Limertinib finished formulations upon request. The Limertinib suppliers may include Limertinib API manufacturers, exporters, distributors and traders.
Limertinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Limertinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Limertinib GMP manufacturer or Limertinib GMP API supplier for your needs.
A Limertinib CoA (Certificate of Analysis) is a formal document that attests to Limertinib's compliance with Limertinib specifications and serves as a tool for batch-level quality control.
Limertinib CoA mostly includes findings from lab analyses of a specific batch. For each Limertinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Limertinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Limertinib EP), Limertinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Limertinib USP).
